Incidence of Second primary Malignancies in prostate Cancer patients with bone metastases – an observational retrospective cohort study in Sweden (SMARCOS)

Study identification

• EU PAS number:
  EUPAS15491
• Study ID:
  26899
• Official title and acronym:
  Incidence of Second primary Malignancies in prostate Cancer patients with bone metastases – an observational retrospective cohort study in Sweden (SMARCOS)
• DARWIN EU® study:
  No
• Study countries:
  Sweden
• Study description:
  An observational retrospective cohort study in Sweden to investigate incidence of second primary malignancies in prostate cancer patients with bone metastases
• Study status:
  Finalised

Research institutions and networks

Institutions

EPID Research Oy

Study timelines

Date when funding contract was signed

Planned: 20/11/2015

Actual: 20/11/2015

Study start date

Planned: 15/11/2016

Actual: 15/11/2016

Date of final study report

Planned: 06/10/2017

Actual: 06/10/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Bayer HealthCare Pharmaceutical Inc

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable